Genetic Analysis in Japanese Kindreds of Congenital Type I Antithrombin Deficiency Causing Thrombosis

Summary

We have identified two novel minor deletions (case 1; -TA or -AT at nucleotide 9831-3 in exon 5 and case 2; -A at nucleotide 7640-1 in exon 4), one novel nonsense mutation (case 3; TAT to TAA at nucleotide 7491 in exon 4), and one recurrent nonsense mutation (case 4; CGA to TGA at nucleotide 5381 in exon 3A) in Japanease kindreds with congenital type I antithrombin deficiency. The deletion detected in case 1 represented a symmetric element (CTCTGTCTC) and possessed a direct repeat (CTCTATGTCTC). The deletion in case 2 was recognized in a consensus sequence (TGAAT) and possessed a direct repeat (GATGAA). The nonsense mutation in case 3 formed a palindrome (CCGTTAACGG) and that in case 4 was caused hy a CpG dinucleotide mutation. These results confirm that the mutations of congenital type I antithrombin deficiency are not random events but are influenced strongly by DNA sequences.

• References

• 1 Barrowcliffe TW. Antithrombin III and heparin. In: Bloom AL, Thomas DP. (eds). Haemost Thromb. Edinburgh: Churchill Livingstone; 1987: 849-869
• 2 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 3 Bjork I, Olson ST, Shore JD. Molecular mechanisms of the accelerating effect of heparin on the reactions between antithrombin and the clotting proteinases. In: Heparin: Chemical and Biological Properties, Clinical Applications. Lane DA, Lindahl U. (eds). London: Edward Arnold; 1989. pp 229-255
• 4 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Tromb Diathes Haemorrh 1965; 13: 516-530
• 5 Lane DA, Olds RJ, Boisclair M, Chowdhury V, Thein SL, Cooper DN, Blajchman M, Perry D, Emmerich J, Aiach M. Antithrombin III mutation database; First update. Thromb Haemost 1993; 70: 361-369
• 6 Perry DJ, Carrell RW. Hydrolink gels: a rapid and simple approach to the detection of DNA mutations in thromboembolic disease. J Clin Pathol 1992; 45: 158-160
• 7 Emmerich J, Chadeuf G, Alhenc-Gelas M, Gouault-Heilman M, Toulon P, Fiessinger JN, Aiach M. Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6. Thromb Haemost 1994; 72: 534-539
• 8 Laurel CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45
• 9 Sas G, Pepper D, Cash J. Investigations on antithrombin III in normal plasma and serum. Br J Haematol 1975; 30: 265
• 10 Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones Jr HW, Rary JM. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-1249
• 11 Hultman T, Stahl S, Hormes E, Uhlen M. A Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 1989; 17: 4937-4946
• 12 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467
• 13 Olds RJ, Lane DA, Ireland H, Leone G, De StefanoV, Wiesel ML, Caze-nave JP, Thein SL. Novel point mutations leading to type I antithrombin deficiency and thrombosis. Brit J Haematol 1991; 78: 408-413
• 14 Gandrille S, Vidaud D, Emmerich J, Clauser E, Aiach M. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IlIa and a frameshift in exon IV. Brit J Haematol 1991; 78: 414-420
• 15 Femandez-Rachubinski F, Rachubinski RA, Blajchman MA. Partial deletion of an antithrombin III allele in a kindred with a type I deficiency. Blood 1992; 80: 1476-1485
• 16 Olds RJ, Lane DA, Chowdhury V, Stefano VD, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32: 4216-4224
• 17 Prochownik EV, Antonarakis S, Bauer KA, Rosenberg RD, Fearon ER, Orkin SH. Molecular heterogeneity of inherited antithrombin III deficiency. N Engl J Med 1983; 308: 1549-1552
• 18 Myers R, Maniatis T, Lerman LS. Detection and localization of single base changes by denaturing gradient electrophoresis. Methods in Enzymology 1987; 155: 501-517
• 19 Sarkar G, Yoon HS, Sommer SS. Dideoxy fingerprinting (ddF): A rapid and efficient screen for the presence of mutations. Genomics 1992; 13: 441-443
• 20 Cotton RGH, Rodrigues NR, Campbell RD. Reactivity of cytosine and thymine in single base pair mismatches with hydroxyamine and osmium tetroxide and its application to the study of mutations. Proc Nat Acad Sci USA 1988; 85: 4397-4401
• 21 Lane DA, Olds RR, Thein SL. Antithrombin and its deficiency states. Blood Coag Fibrinolysis 1992; 03: 315-341
• 22 Prochownik EV. Relationship between an enhancer element in the human antithrombin gene and an immunoglobulin light-chain gene enhancer. Nature 1985; 316: 845-848
• 23 Krawczak M, Cooper DN. Gene deletions causing human genetic disease: mechanism of mutagenesis and the role of the local DNA sequence environment. Hum Genet 1991; 86: 425-441
• 24 Daly ME, Perry DJ, Harper PL, Carrell RW. The molecular basis of quantitative antithrombin deficiency in 8 unrelated families. Brit J Haematol 1992; 80: 15
• 25 Chowdhury V, Olds RJ, Lane DA, Conard J, Pabinger I, Ryan K, Bauer K, Bhavani M, Abildgaard U, Finazzi G, Castaman G, Mannucci PM, Thein SL. Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening. Brit J Haematol 1993; 84: 656-661
• 26 Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, Inouye M. Frameshift mutations and the genetic code. Cold Spring Harbor Symp Quant Biol 1966; 31: 77-84
• 27 Kunkel TA. Misalignment-mediated DNA synthesis errors. Biochemistry 1990; 29: 8003-8011
• 28 Grundy CB, Thomas F, Millar DS, Krawczak M, Melissari E, Lindo V, Moffat E, Kakkar VV, Cooper DN. Recurrent deletion in the human antithrombin III gene. Blood 1991; 78: 1027-1032
• 29 Ripley LS. Model for the participation of quasi-palindromic DNA sequences in frameshift mutation. Proc Natl Acad Sci USA 1982; 79: 4128-4132
• 30 Vidaud D, Emmerich J, Sirieix ME, Sie P, Alhenc-Gelas M, Aiach M. Molecular basis for antithrombin III type I deficiency: 3 novel mutations located in exon IV. Blood 1991; 78: 2305-2309
• 31 ds RJ, Lane DA, Ireland H, Finazzi G, Barbui T, Abildgaard U, Girolami A, Thein SL. A common point mutation producing type la antithrombin III deficiency: AT 129 CGA to TGA (Arg to Stop). Thrombos Res 1991; 64: 621-625
• 32 Tomonori A, Iwahana H, Yoshimoto K, Shigekiyo T, Saito S, Itakura M. Two new nonsense mutations in type la antithrombin III deficiency at Leu 140 and Arg 197. Thromb Haemost 1992; 68: 455-459
• 33 Vidaud D, Gandrille S, Emmerich J. Identification of six novel mutations responsible for type I AT III deficiencies. Thromb Haemost 1991; 65: 762